UBS’s Axcelis ACLS Stock Holding History

UBS’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-250	Closed	-$2K	–	10362
2014 Q1	$2K	Sell	250 -500	-67%	-$4.6K	﹤0.01%	9986
2013 Q4	$7K	Buy	+750	New	+$6.81K	﹤0.01%	9292

Other funds holding ACLS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Schneider Capital Management Berwyn, Pennsylvania $175M AUM 42.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

UBS's ACLS Position: Q3 2014 in Review

UBS increased its Axcelis (ACLS) stake by 6% in Q3 2014, buying an estimated $57.6K and bringing the position to 136,172 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3505.

UBS first reported a position in ACLS in Q2 2013 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold ACLS as of Q3 2014.

UBS held 136,172 shares of Axcelis worth $1.08M as of Q3 2014.
UBS bought 7,675 Axcelis shares in Q3 2014, an estimated $57.6K.
Axcelis made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3505 holding.
UBS first reported a position in Axcelis in Q2 2013 and has held it in 6 quarters since.
88 funds tracked by Wall St. Rank held Axcelis as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.